The IMT device is not a cure for macular degeneration, but replaces the eye’s natural lens and serves as a way to improve patients’ vision.
The device received FDA clearance in 2010.
More Articles on Ophthalmology:
Dr. Michael Manning Partners With Suncoast Eye Clinic
Vitra Multispot Laser System Receives FDA 510(k) Clearance
Aloha Laser Vision Offers In-Office Prescription Medication
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
